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Palliative radiation therapy is a mainstay in the management 
of symptoms among patients with advanced and metastatic 
cancers. However, there is a latent period between the 
delivery of therapy and the hoped for response to it. As such, 
patients should not receive therapy unless an estimate of 
their expected survival is first made. Acute side effects 
cannot be justified unless there is a reasonable expectation 
that patients may live long enough to benefit from therapy. 
This presentation will summarise the difficulties radiation 
oncologists have had historically with predicting survival for 
their patients, it will highlight studies of palliative radiation 
therapy among patients nearing the end of life, it will 
present prognostic models from the literature that are most 
applicable to those practicing palliative radiation therapy, 
and it will focus on topics that are in need of and are well 
suited to future research in this important area of study.     
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The primary goal of screening is the early detection of 
asymptomatic, previously unrecognized malignancy when 
treatment is more effective than if it were instituted after 
development of signs or symptoms. Screening for metastatic 
disease has historically been used to narrow therapeutic 
options and avoid futile interventions. But in the 
oligometastatic era - where the separation between curative- 
and palliative-intent radiotherapy is becoming less distinct – 
case-finding for the purposes of radical treatment of low 
volume distant metastases is increasingly common, despite 
the lack of clarity regarding the impact on clinical outcomes, 
quality of life and health care costs. Systematic risk-
stratification would ideally enable the selective utilization of 
scarce resources, avoiding test-related complications along 
with delays in initiation of treatment awaiting results which 
have little likelihood of altering management in the majority 
of patients. Potential benefits of different modalities will be 
reviewed, as well as issues to be considered in defining both 
an appropriate target population and screening approach. 
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In most departments, up to 40% of all radiation treatments 
are given with palliative intent. This includes treatment of 
metastatic sites of disease and locally advanced primary 
disease. Over the last 10 years with the availability of new 
technologies, we have seen an increasing complexity of 
palliative radiation treatments particularly in the setting of 
oligometastatic disease. Coupled with this, advances in 
systemic therapies in many disease sites have translated into 
patients with metastatic disease living longer. Unlike curative 
intent treatment which is largely protocol driven, palliative 
intent treatment requires knowledge of a multitude of 
patient, disease and treatment factors and the ability to 
accurately predict prognosis in order to individualise 
fractionation and treatment technique. Palliative 
radiotherapy is becoming recognised internationally as a sub 
speciality and it is becoming increasingly important that we 
recognise the need for formalised palliative care training 
within our speciality. Through international collaboration we 
can develop core competencies for our trainees, encourage 
palliative radiotherapy rotations and fellowship 
opportunities, and foster enthusiasm for palliative 
radiotherapy research in the future striving to deliver 
evidence-based, convenient and effective treatment for 
patients with the fewest possible side effects.  
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The concept of magnetic resonance image-guided radiation 
therapy (MR-IGRT) has been under development for the past 
few years, with the first clinical system implemented and in 
use since January of 2014. This system consists of a split 
0.35T MR scanner straddled by three 60Co sources mounted on 
a ring gantry. The on-board MR shares an isocenter with the 
RT system and is capable of capturing high resolution 
volumetric images of the patient in the treatment position, 
as well as real-time planar cine images during treatment 
delivery.  
The availability of on-board MR images offers the capability 
to visualize soft tissue for better localization, as well as 
potential treatment adaptation based on the geometry of the 
day. The MR-IGRT system implemented in our clinic has an 
integrated treatment planning system with fast dose re-
optimization, and dose calculation which allows modification 
of structure contours, followed by re-planning while the 
patient remains in the treatment position.  
While the topic of online adaptive therapy has been of 
significant interest in research studies over the past two 
decades, the clinical implementation has been straggling 
behind due to the stringent system requirements necessary to 
make the process clinically realistic.  
Here we report on the clinical implementation of the first 
online adaptive therapy system, the workflow and staffing 
considerations, patient specific quality assurance, and the 
achievable overall treatment times from initial patient setup 
to completion of the treatment.  
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